Review





Similar Products

src family tyrosine kinase inhibitor pp1  (Millipore)
90
Millipore src family tyrosine kinase inhibitor pp1
Src Family Tyrosine Kinase Inhibitor Pp1, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src family tyrosine kinase inhibitor pp1/product/Millipore
Average 90 stars, based on 1 article reviews
src family tyrosine kinase inhibitor pp1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pp1 (potent, selective src family kinase inhibitor)  (Tocris)
90
Tocris pp1 (potent, selective src family kinase inhibitor)
Pp1 (Potent, Selective Src Family Kinase Inhibitor), supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pp1 (potent, selective src family kinase inhibitor)/product/Tocris
Average 90 stars, based on 1 article reviews
pp1 (potent, selective src family kinase inhibitor) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pp1 (potent, selective src family kinase inhibitor  (Tocris)
90
Tocris pp1 (potent, selective src family kinase inhibitor
Pp1 (Potent, Selective Src Family Kinase Inhibitor, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pp1 (potent, selective src family kinase inhibitor/product/Tocris
Average 90 stars, based on 1 article reviews
pp1 (potent, selective src family kinase inhibitor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
the src family kinase inhibitor pp1  (Millipore)
90
Millipore the src family kinase inhibitor pp1
The Src Family Kinase Inhibitor Pp1, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/the src family kinase inhibitor pp1/product/Millipore
Average 90 stars, based on 1 article reviews
the src family kinase inhibitor pp1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
selective inhibitor src family tyrosine kinases, pp1  (Tocris)
90
Tocris selective inhibitor src family tyrosine kinases, pp1
Selective Inhibitor Src Family Tyrosine Kinases, Pp1, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/selective inhibitor src family tyrosine kinases, pp1/product/Tocris
Average 90 stars, based on 1 article reviews
selective inhibitor src family tyrosine kinases, pp1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
10 μm src family kinase inhibitor pp1 (4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-d-3,4-pyrimidine  (Millipore)
90
Millipore 10 μm src family kinase inhibitor pp1 (4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-d-3,4-pyrimidine
10 μm Src Family Kinase Inhibitor Pp1 (4 Amino 5 (4 Methylphenyl) 7 (T Butyl)Pyrazolo D 3,4 Pyrimidine, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/10 μm src family kinase inhibitor pp1 (4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-d-3,4-pyrimidine/product/Millipore
Average 90 stars, based on 1 article reviews
10 μm src family kinase inhibitor pp1 (4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-d-3,4-pyrimidine - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
src family kinase inhibitor pp1  (Millipore)
90
Millipore src family kinase inhibitor pp1
MMP-9 concentrations in supernatants from PMN cultures pre-treated with 10 μM <t>PP1</t> and/or 1 μM AS604850 and treated with 100 nM fMLP on (A) PEG hydrogels, (B) PDMS, (C) TCPS, (D) GP hydrogels, and (E) 15 weight percent gelatin hydrogels at 2 h. Results represent the mean ± standard deviation with each data point representing a different donor, n = 4–6. *: significant difference from untreated (−/−), p = 0.01–0.05; ***: significant difference from untreated, p = 0.0001–0.001; ****: significant difference from untreated, p < 0.0001.
Src Family Kinase Inhibitor Pp1, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src family kinase inhibitor pp1/product/Millipore
Average 90 stars, based on 1 article reviews
src family kinase inhibitor pp1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
src family kinase inhibitor pp1 (4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-d-3,4-pyrimidine  (Millipore)
90
Millipore src family kinase inhibitor pp1 (4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-d-3,4-pyrimidine
MMP-9 concentrations in supernatants from PMN cultures pre-treated with 10 μM <t>PP1</t> and/or 1 μM AS604850 and treated with 100 nM fMLP on (A) PEG hydrogels, (B) PDMS, (C) TCPS, (D) GP hydrogels, and (E) 15 weight percent gelatin hydrogels at 2 h. Results represent the mean ± standard deviation with each data point representing a different donor, n = 4–6. *: significant difference from untreated (−/−), p = 0.01–0.05; ***: significant difference from untreated, p = 0.0001–0.001; ****: significant difference from untreated, p < 0.0001.
Src Family Kinase Inhibitor Pp1 (4 Amino 5 (4 Methylphenyl) 7 (T Butyl)Pyrazolo D 3,4 Pyrimidine, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src family kinase inhibitor pp1 (4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-d-3,4-pyrimidine/product/Millipore
Average 90 stars, based on 1 article reviews
src family kinase inhibitor pp1 (4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-d-3,4-pyrimidine - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


MMP-9 concentrations in supernatants from PMN cultures pre-treated with 10 μM PP1 and/or 1 μM AS604850 and treated with 100 nM fMLP on (A) PEG hydrogels, (B) PDMS, (C) TCPS, (D) GP hydrogels, and (E) 15 weight percent gelatin hydrogels at 2 h. Results represent the mean ± standard deviation with each data point representing a different donor, n = 4–6. *: significant difference from untreated (−/−), p = 0.01–0.05; ***: significant difference from untreated, p = 0.0001–0.001; ****: significant difference from untreated, p < 0.0001.

Journal: Biomaterials

Article Title: Biomaterials differentially regulate Src kinases and phosphoinositide 3-kinase-γ in polymorphonuclear leukocyte primary and tertiary granule release

doi: 10.1016/j.biomaterials.2015.01.050

Figure Lengend Snippet: MMP-9 concentrations in supernatants from PMN cultures pre-treated with 10 μM PP1 and/or 1 μM AS604850 and treated with 100 nM fMLP on (A) PEG hydrogels, (B) PDMS, (C) TCPS, (D) GP hydrogels, and (E) 15 weight percent gelatin hydrogels at 2 h. Results represent the mean ± standard deviation with each data point representing a different donor, n = 4–6. *: significant difference from untreated (−/−), p = 0.01–0.05; ***: significant difference from untreated, p = 0.0001–0.001; ****: significant difference from untreated, p < 0.0001.

Article Snippet: PMN pre-treatment with Src family kinase inhibitor PP1 and/or PI3K-γ inhibitor AS604850 After isolation, PMNs were suspended at a concentration of 2 × 10 6 cells/ml in RPMI-1640 medium supplemented with 10% AHS and 10 μM Src family kinase inhibitor PP1 (4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-d-3,4-pyrimidine; EMD Millipore, Billerica, MA), 1 μM PI3K-γ inhibitor AS604850 (Echelon Biosciences Inc., Salt Lake City, UT), or an equivalent volume of dimethyl sulfoxide (DMSO; Sigma–Aldrich, St. Louis, MO).

Techniques: Standard Deviation

MPO concentrations in supernatants from PMN cultures pre-treated with 10 μM PP1 and/or 1 μM AS604850 on (A) PEG hydrogels, (B) PDMS, (C) TCPS, (D) GP hydrogels, and (E) 15 weight percent gelatin hydrogels at 2 h. Results represent the mean ± standard deviation with each data point representing a different donor, n = 4–6. *: significant difference from untreated (−/−), p = 0.01–0.05; ***: significant difference from untreated, p = 0.0001–0.001; ****: significant difference from untreated, p < 0.0001.

Journal: Biomaterials

Article Title: Biomaterials differentially regulate Src kinases and phosphoinositide 3-kinase-γ in polymorphonuclear leukocyte primary and tertiary granule release

doi: 10.1016/j.biomaterials.2015.01.050

Figure Lengend Snippet: MPO concentrations in supernatants from PMN cultures pre-treated with 10 μM PP1 and/or 1 μM AS604850 on (A) PEG hydrogels, (B) PDMS, (C) TCPS, (D) GP hydrogels, and (E) 15 weight percent gelatin hydrogels at 2 h. Results represent the mean ± standard deviation with each data point representing a different donor, n = 4–6. *: significant difference from untreated (−/−), p = 0.01–0.05; ***: significant difference from untreated, p = 0.0001–0.001; ****: significant difference from untreated, p < 0.0001.

Article Snippet: PMN pre-treatment with Src family kinase inhibitor PP1 and/or PI3K-γ inhibitor AS604850 After isolation, PMNs were suspended at a concentration of 2 × 10 6 cells/ml in RPMI-1640 medium supplemented with 10% AHS and 10 μM Src family kinase inhibitor PP1 (4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-d-3,4-pyrimidine; EMD Millipore, Billerica, MA), 1 μM PI3K-γ inhibitor AS604850 (Echelon Biosciences Inc., Salt Lake City, UT), or an equivalent volume of dimethyl sulfoxide (DMSO; Sigma–Aldrich, St. Louis, MO).

Techniques: Standard Deviation

MMP-9 concentrations in supernatants from PMN cultures pre-treated with 10 μM PP1 and/or 1 μM AS604850 on (A) PEG hydrogels, (B) PDMS, (C) TCPS, (D) GP hydrogels, and (E) 15 weight percent gelatin hydrogels at 2 h. Results represent the mean ± standard deviation with each data point representing a different donor, n = 4–6. **: significant difference from untreated (−/−), p = 0.001–0.01; ***: significant difference from untreated, p = 0.0001–0.001; ****: significant difference from untreated, p < 0.0001.

Journal: Biomaterials

Article Title: Biomaterials differentially regulate Src kinases and phosphoinositide 3-kinase-γ in polymorphonuclear leukocyte primary and tertiary granule release

doi: 10.1016/j.biomaterials.2015.01.050

Figure Lengend Snippet: MMP-9 concentrations in supernatants from PMN cultures pre-treated with 10 μM PP1 and/or 1 μM AS604850 on (A) PEG hydrogels, (B) PDMS, (C) TCPS, (D) GP hydrogels, and (E) 15 weight percent gelatin hydrogels at 2 h. Results represent the mean ± standard deviation with each data point representing a different donor, n = 4–6. **: significant difference from untreated (−/−), p = 0.001–0.01; ***: significant difference from untreated, p = 0.0001–0.001; ****: significant difference from untreated, p < 0.0001.

Article Snippet: PMN pre-treatment with Src family kinase inhibitor PP1 and/or PI3K-γ inhibitor AS604850 After isolation, PMNs were suspended at a concentration of 2 × 10 6 cells/ml in RPMI-1640 medium supplemented with 10% AHS and 10 μM Src family kinase inhibitor PP1 (4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-d-3,4-pyrimidine; EMD Millipore, Billerica, MA), 1 μM PI3K-γ inhibitor AS604850 (Echelon Biosciences Inc., Salt Lake City, UT), or an equivalent volume of dimethyl sulfoxide (DMSO; Sigma–Aldrich, St. Louis, MO).

Techniques: Standard Deviation